PriceTargets.com logo

Semler Scientific - SMLR Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $74.25
  • Forecasted Upside: 265.22%
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$20.33 As of 12/4/2025 05:00 PM ET
▼ -0.11 (-0.54%)

This chart shows the closing price for SMLR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Semler Scientific Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SMLR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SMLR

Analyst Price Target is $74.25
▲ +265.22% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Semler Scientific in the last 3 months. The average price target is $74.25, with a high forecast of $86.00 and a low forecast of $60.00. The average price target represents a 265.22% upside from the last price of $20.33.

This chart shows the closing price for SMLR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 5 polled investment analysts is to moderate buy stock in Semler Scientific. This rating has held steady since September 2025, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 1 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 1 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 1 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/2/2025Weiss RatingsUpgradeSell (D+) ➝ Hold (C-)
11/26/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
11/20/2025Weiss RatingsDowngradeHold (C-) ➝ Sell (D+)
10/8/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
9/27/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
9/23/2025BenchmarkLower TargetBuy ➝ Buy$101.00 ➝ $86.00
9/19/2025Maxim GroupLower TargetBuy ➝ Buy$95.00 ➝ $80.00
8/6/2025Cantor FitzgeraldLower TargetOverweight ➝ Overweight$61.00 ➝ $60.00
7/28/2025Cantor FitzgeraldInitiated CoverageOverweight$61.00
7/28/2025Cantor FitzgeraldInitiated CoverageOverweight$61.00
7/9/2025Maxim GroupUpgradeStrong-Buy$95.00
7/8/2025BenchmarkInitiated CoverageBuy$101.00
1/24/2025Lake Street CapitalBoost TargetBuy ➝ Buy$40.00 ➝ $71.00
5/8/2024Lake Street CapitalUpgradeStrong-Buy
11/2/2022B. RileyDowngradeBuy ➝ Neutral$60.00 ➝ $45.00
5/3/2022B. RileyLower Target$70.00 ➝ $60.00
3/22/2022Colliers SecuritiesReiterated RatingBuy
3/7/2022B. RileyLower TargetBuy$145.00 ➝ $70.00
3/1/2022Lake Street CapitalLower Target$175.00 ➝ $100.00
2/28/2022Colliers SecuritiesReiterated RatingBuy$182.00
11/2/2021Colliers SecuritiesReiterated RatingBuy$181.00
11/2/2021Lake Street CapitalLower TargetBuy$200.00 ➝ $175.00
11/2/2021B. RileyLower TargetBuy$175.00 ➝ $145.00
10/26/2021B. RileyReiterated RatingBuy$151.00 ➝ $175.00
9/28/2021Lake Street CapitalBoost TargetBuy$150.00 ➝ $200.00
9/28/2021Colliers SecuritiesReiterated RatingBuy ➝ Average$151.00
8/4/2021B. RileyReiterated RatingBuy$151.00
7/30/2021Colliers SecuritiesReiterated RatingBuy$147.00
5/4/2021B. RileyBoost TargetBuy$147.00 ➝ $151.00
4/27/2021B. RileyInitiated CoverageBuy$147.00
2/25/2021B. RileyBoost TargetBuy$100.00 ➝ $121.00
1/19/2021B. RileyReiterated RatingBuy$94.00 ➝ $100.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

0.32 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 12 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 17 very positive mentions
  • 24 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
6/7/2025
  • 5 very positive mentions
  • 29 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
Mentions as of
7/7/2025
  • 5 very positive mentions
  • 32 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 6 very positive mentions
  • 27 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 11 very positive mentions
  • 111 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 10 very positive mentions
  • 79 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
11/4/2025
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Semler Scientific logo
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.
Read More

Today's Range

Now: $20.33
Low: $20.08
High: $20.89

50 Day Range

MA: $24.88
Low: $18.47
High: $31.44

52 Week Range

Now: $20.33
Low: $17.41
High: $81.56

Volume

505,507 shs

Average Volume

503,343 shs

Market Capitalization

$308.20 million

P/E Ratio

7.31

Dividend Yield

N/A

Beta

1.35

Frequently Asked Questions

What sell-side analysts currently cover shares of Semler Scientific?

The following sell-side analysts have issued stock ratings on Semler Scientific in the last year: Benchmark Co., Cantor Fitzgerald, Lake Street Capital, Maxim Group, Wall Street Zen, and Weiss Ratings.
View the latest analyst ratings for SMLR.

What is the current price target for Semler Scientific?

0 Wall Street analysts have set twelve-month price targets for Semler Scientific in the last year. Their average twelve-month price target is $74.25, suggesting a possible upside of 265.2%. Benchmark Co. has the highest price target set, predicting SMLR will reach $86.00 in the next twelve months. Cantor Fitzgerald has the lowest price target set, forecasting a price of $60.00 for Semler Scientific in the next year.
View the latest price targets for SMLR.

What is the current consensus analyst rating for Semler Scientific?

Semler Scientific currently has 1 hold rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for SMLR.

What other companies compete with Semler Scientific?

Other companies that are similar to Semler Scientific include AxoGen, SS Innovations International, BioLife Solutions, iRadimed and MiMedx Group. Learn More about companies similar to Semler Scientific.

How do I contact Semler Scientific's investor relations team?

Semler Scientific's physical mailing address is 2340-2348 Walsh Avenue, Suite 2344, Santa Clara, CA 95051, United States. The company's listed phone number is 877-774-4211 and its investor relations email address is [email protected]. The official website for Semler Scientific is www.semlerscientific.com. Learn More about contacing Semler Scientific investor relations.